These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14686560)

  • 1. Reporting suspected adverse drug reactions: the importance of providing full and accurate data.
    Brooking J
    Int J Clin Pract; 2003 Nov; 57(9):748-9. PubMed ID: 14686560
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse drug reaction of the month--a new series.
    Rawlins MD; Breckenridge AM; Wood SM; Waller PC; Coulson R
    Postgrad Med J; 1997 Jul; 73(861):385. PubMed ID: 9338019
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of internal reporting criteria on suspected adverse drug reactions submitted to MedWatch.
    Smith KM; Lawson AP; Tuteja S
    Am J Health Syst Pharm; 2006 May; 63(10):949-52. PubMed ID: 16675652
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse drug reactions.
    Shuttleworth A
    Nurs Times; 2006 Jul 25-31; 102(30):58. PubMed ID: 16903313
    [No Abstract]   [Full Text] [Related]  

  • 5. Reporting of adverse drug reactions: practice in the UK.
    Morrison-Griffiths S; Pirmohamed M; Walley T
    Nurs Times; 1998 Mar 11-17; 94(10):52-4. PubMed ID: 9735778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When to report adverse drug reactions in children?
    Barton C; Hawcutt DB
    Arch Dis Child; 2015 Jul; 100(7):682-3. PubMed ID: 25854873
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription-event monitoring and reporting of adverse drug reactions.
    Heeley E; Riley J; Layton D; Wilton LV; Shakir SA
    Lancet; 2001 Dec; 358(9296):1872-3. PubMed ID: 11741629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nurse reporting of adverse events caused by medicines.
    Hunt JM; Gjoka G
    Nurs Times; 2003 Dec 9-15; 99(49):24-5. PubMed ID: 14705341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct reporting of suspected adverse drug reactions by patients.
    Choonara I
    J R Soc Med; 2004 Jul; 97(7):316-7. PubMed ID: 15229253
    [No Abstract]   [Full Text] [Related]  

  • 10. GPs are urged to report adverse drug reactions after a 37% slump over nine years.
    Wise J
    BMJ; 2013 Feb; 346():f690. PubMed ID: 23377613
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring suspected adverse reactions.
    Davidson DL
    Vet Rec; 1997 Apr; 140(15):407. PubMed ID: 9141227
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse drug events: what's the truth?
    Dean B
    Qual Saf Health Care; 2003 Jun; 12(3):165-6. PubMed ID: 12792003
    [No Abstract]   [Full Text] [Related]  

  • 13. A case for co-ordinated investigation and reporting of hypersensitivity-type drug reactions in the UK.
    Watkins J; Wild G; Bex S; Ward AM
    Anaesthesia; 2000 Nov; 55(11):1127-8. PubMed ID: 11203409
    [No Abstract]   [Full Text] [Related]  

  • 14. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R; Frassetto L; Tsourounis C; Segal ES; Kim S
    Postgrad Med; 2010 Nov; 122(6):154-64. PubMed ID: 21084792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward standardized reporting of drug interactions: the READI checklist for anecdotal reports.
    Aronson JK
    Expert Rev Clin Pharmacol; 2015; 8(4):399-409. PubMed ID: 26018632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveying adverse event rates: lessons from a virosomal hepatitis A vaccine.
    Herzog C
    Expert Rev Vaccines; 2012 Apr; 11(4):383-5. PubMed ID: 22551020
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse drug reactions and reporting.
    Witte R
    Clin J Oncol Nurs; 2000; 4(4):181, 184. PubMed ID: 11261100
    [No Abstract]   [Full Text] [Related]  

  • 19. An overview of the current status of national reporting systems for adverse reactions to dental materials.
    van Noort R; Gjerdet NR; Schedle A; Björkman L; Berglund A
    J Dent; 2004 Jul; 32(5):351-8. PubMed ID: 15193782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance on the turn? Adverse reactions methods in 2012.
    Herxheimer A
    Br J Gen Pract; 2012 Aug; 62(601):400-1. PubMed ID: 22867653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.